Researchers continue to excited about the medication , a groundbreaking dual agonist showing significant data in initial trials for weight reduction . It acts by targeting two hormones : GLP-1 and GIP, https://geraldjoow184272.estate-blog.com/39646176/the-new-prospect-for-size-reduction